Indication
Child-Pugh Class A
2 clinical trials
3 products
1 drug
Clinical trial
International Randomized Study of Transarterial Chemoembolization (TACE) Versus Stereotactic Body Radiotherapy (SBRT) / Stereotactic Ablative Radiotherapy (SABR) for Residual or Recurrent Hepatocellular Carcinoma After Initial TACEStatus: Terminated, Estimated PCD: 2022-12-31
Product
Embolic agentProduct
lipiodolClinical trial
A Phase Ib/ II Study of Sorafenib and Pembrolizumab in Advanced Hepatocellular Cancer (HCC)Status: Active (not recruiting), Estimated PCD: 2023-03-07
Drug
mFOLFOX6Product
Sorafenib